SCHEMBL31695205

SCHEMBL31695205

C=CC[C@]1(C(=O)OC)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@@H]2OC(C)(C)O[C@@H]2CN=[N+]=[N-])O1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ NANP Q8TBE9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31695155 0.92 NANP (0.33) NANP
SCHEMBL31695052 0.90 — —
SCHEMBL26926801 0.84 NANP (0.32) NANP
SCHEMBL26927561 0.83 — —
SCHEMBL31502433 0.76 HPGD (0.33) NANP
SCHEMBL15090252 0.76 NANP (0.48) NANP
SCHEMBL16362518 0.76 NANP (0.48) NANP
SCHEMBL31695026 0.76 NANP (0.48) NANP
SCHEMBL31695161 0.75 — —
SCHEMBL16392569 0.72 BDNF (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313574-A1 SIALIC ACID DERIVATIVES AND METHODS OF USING SAME EISAI R&D MANAGEMENT CO., LTD. (JP) 2025-10-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313574-A1 SIALIC ACID DERIVATIVES AND METHODS OF USING SAME NEU1, NEU2, NEU4 NANP 63/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback